Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Oct 2023 15:02

RNS Number : 5657O
Ergomed plc
03 October 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7ZCY67

Issuer Name

ERGOMED PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

Name

City of registered office

Country of registered office

Morgan Stanley

Wilmington, Delaware

USA

4. Details of the shareholder

Name

City of registered office

Country of registered office

Morgan Stanley & Co. International plc

London

UNITED KINGDOM

5. Date on which the threshold was crossed or reached

29-Sep-2023

6. Date on which Issuer notified

03-Oct-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.134230

0.000000

5.134230

2615511

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7ZCY67

2615511

5.134230

Sub Total 8.A

2615511

5.134230%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Morgan Stanley (Chain 1)

Morgan Stanley (Chain 1)

Morgan Stanley International Holdings Inc.

Morgan Stanley (Chain 1)

Morgan Stanley International Limited

Morgan Stanley (Chain 1)

Morgan Stanley Investments (UK)

Morgan Stanley (Chain 1)

Morgan Stanley & Co. International plc

5.134230

5.134230%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

03-Oct-2023

13. Place Of Completion

Glasgow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFSAFDDEDSEIS
Date   Source Headline
1st Mar 20217:00 amRNSTotal Voting Rights
25th Feb 20218:42 amRNSHolding(s) in Company
10th Feb 20217:00 amRNSNotice of Preliminary Results
26th Jan 20218:42 amEQSErgomed (ERGO): PrimeVigilance excels; CRO strengthened in US
26th Jan 20217:00 amRNSErgomed 2020 Trading Update
4th Jan 20217:00 amRNSTotal Voting Rights and Block Listing Return
15th Dec 20208:00 amEQSErgomed (ERGO): MedSource acquisition to boost US CRO business
14th Dec 20207:00 amRNSAcquisition of MedSource
24th Nov 20204:34 pmRNSHolding(s) in Company
18th Nov 20207:00 amRNSShare Capital Reduction Effective
11th Nov 20207:00 amRNSErgomed to Present at Jefferies Conference
2nd Nov 20207:00 amRNSTotal Voting Rights
21st Oct 20205:26 pmRNSHolding(s) in Company
19th Oct 202010:12 amRNSResult of General Meeting
12th Oct 20205:51 pmRNSHolding(s) in Company
1st Oct 20207:00 amRNSProposed Capital Reduction
1st Oct 20207:00 amRNSTotal Voting Rights
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:03 amRNSPrice Monitoring Extension
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:35 pmRNSPrice Monitoring Extension
22nd Sep 20207:00 amRNSInterim Results
9th Sep 20201:50 pmRNSHolding(s) in Company
1st Sep 20207:00 amRNSTotal Voting Rights
20th Aug 202011:32 amRNSHolding(s) in Company
20th Aug 20207:00 amRNSNotice of Interim Results
14th Aug 20204:19 pmRNSHoldings in Company
4th Aug 20207:00 amRNSExercise of Share Options and Total Voting Rights
3rd Aug 20207:00 amRNSTotal Voting Rights
23rd Jul 20201:02 pmRNSHoldings in Company
22nd Jul 202012:57 pmRNSHolding(s) in Company
21st Jul 20202:14 pmRNSHoldings in Company
21st Jul 20202:13 pmRNSHoldings in Company
21st Jul 20207:00 amRNSErgomed H1 2020 Trading Update
20th Jul 20205:35 pmRNSHolding(s) in Company
20th Jul 20202:08 pmRNSHolding(s) in Company
17th Jul 202012:19 pmRNSHolding(s) in Company
15th Jul 202012:03 pmRNSHolding(s) in Company
6th Jul 20204:14 pmRNSExercise of Share Options and Total Voting Rights
1st Jul 20207:00 amRNSTotal Voting Rights & Block Listing Return
29th Jun 20205:17 pmRNSHoldings in Company
10th Jun 20201:43 pmEQSEdison Inv Research Limited: Edison issues flash on Ergomed (ERGO)
10th Jun 202010:53 amRNSResult of AGM
10th Jun 20207:00 amRNSAnnual General Meeting Statement
1st Jun 20207:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSErgomed to Present at Jefferies Conference
18th May 20207:00 amRNSStrategic Partnership in Intelligent Automation
15th May 20207:00 amRNSNotice of AGM and Annual Report and Board Changes
1st May 20207:00 amRNSTotal Voting Rights
6th Apr 20207:00 amRNSErgomed Announces Second COVID-19 Clinical Study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.